Literature DB >> 19366562

The role of Mycoplasma in upper respiratory infections.

Ken B Waites1, T Prescott Atkinson.   

Abstract

Mycoplasma pneumoniae is a common cause of upper and lower respiratory tract infections. Pneumonia is the most clinically important manifestation, but tracheobronchitis and various nonspecific upper respiratory tract symptoms are more typically seen in clinical settings. M. pneumoniae can cause pharyngitis with or without concomitant lower respiratory tract involvement, but it is less commonly detected in other upper respiratory conditions such as otitis media, sinusitis, and the common cold. A variety of methods exist for laboratory diagnosis of M. pneumoniae infection, including culture, serology, and the polymerase chain reaction assay, but each has limitations. This article provides a summary of recent studies that have evaluated the role of M. pneumoniae in upper respiratory tract infections; a brief discussion of its cell biology, pathogenic mechanisms, and epidemiology; and recommendations for laboratory diagnosis and management.

Entities:  

Year:  2009        PMID: 19366562     DOI: 10.1007/s11908-009-0030-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

1.  Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.

Authors:  N Okazaki; M Narita; S Yamada; K Izumikawa; M Umetsu; T Kenri; Y Sasaki; Y Arakawa; T Sasaki
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

2.  Lemierre's syndrome with spondylitis and pulmonary and gluteal abscesses associated with Mycoplasma pneumoniae pneumonia.

Authors:  M Abele-Horn; P Emmerling; J F Mann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-04       Impact factor: 3.267

3.  In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.

Authors:  D Gruson; S Pereyre; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

Authors:  Miyuki Morozumi; Keiko Hasegawa; Reiko Kobayashi; Nagako Inoue; Satoshi Iwata; Haruo Kuroki; Naohisa Kawamura; Eiichi Nakayama; Takeshi Tajima; Kouichi Shimizu; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.

Authors:  Miyuki Morozumi; Satoshi Iwata; Keiko Hasegawa; Naoko Chiba; Reiko Takayanagi; Keita Matsubara; Eiichi Nakayama; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

6.  Mycoplasma pneumoniae infection complicated by severe mucocutaneous lesions.

Authors:  Parham Sendi; Peter Graber; Franka Lepère; Peter Schiller; Werner Zimmerli
Journal:  Lancet Infect Dis       Date:  2008-04       Impact factor: 25.071

7.  Detection of Mycoplasma pneumoniae in serum specimens from patients with mycoplasma pneumonia by PCR.

Authors:  Florian Daxboeck; Gelas Khanakah; Claudia Bauer; Maria Stadler; Hanns Hofmann; Gerold Stanek
Journal:  Int J Med Microbiol       Date:  2005-08       Impact factor: 3.473

8.  The occurrence of Chlamydia pneumoniae, Mycoplasma pneumoniae, and herpesviruses in otitis media with effusion.

Authors:  Merete Storgaard; Britta Tarp; Therese Ovesen; Bent Vinther; Paul L Andersen; Niels Obel; Jørgen S Jensen
Journal:  Diagn Microbiol Infect Dis       Date:  2004-02       Impact factor: 2.803

9.  PCR analysis of nasal polyps, chronic sinusitis, and hypertrophied turbinates for DNA encoding bacterial 16S rRNA.

Authors:  Gerald A Bucholtz; Sherry A Salzman; Fernando B Bersalona; Timothy R Boyle; Victor S Ejercito; Linda Penno; Douglas W Peterson; Gwen E Stone; Andrew Urquhart; Sanjay K Shukla; James K Burmester
Journal:  Am J Rhinol       Date:  2002 May-Jun

10.  Serological evidence of viral or Mycoplasma pneumoniae infection in acute maxillary sinusitis.

Authors:  S Savolainen; H Jousimies-Somer; M Kleemola; J Ylikoski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

View more
  20 in total

1.  Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.

Authors:  Fei Zhao; Min Lv; Xiaoxia Tao; Hui Huang; Binghua Zhang; Zhen Zhang; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

2.  P65 truncation impacts P30 dynamics during Mycoplasma pneumoniae gliding.

Authors:  Benjamin M Hasselbring; Edward S Sheppard; Duncan C Krause
Journal:  J Bacteriol       Date:  2012-04-27       Impact factor: 3.490

3.  Mycoplasma pneumoniae and health outcomes in children with asthma.

Authors:  Pamela R Wood; Jordan C Kampschmidt; Peter H Dube; Marianna P Cagle; Paola Chaparro; Norma S Ketchum; Thirumalai R Kannan; Harjinder Singh; Jay I Peters; Joel B Baseman; Edward G Brooks
Journal:  Ann Allergy Asthma Immunol       Date:  2017-06-19       Impact factor: 6.347

4.  Sialylated Receptor Setting Influences Mycoplasma pneumoniae Attachment and Gliding Motility.

Authors:  Caitlin R Williams; Li Chen; Ashley D Driver; Edward A Arnold; Edward S Sheppard; Jason Locklin; Duncan C Krause
Journal:  Mol Microbiol       Date:  2018-09-30       Impact factor: 3.501

5.  Versatile Methodology for Glycosurfaces: Direct Ligation of Nonderivatized Reducing Saccharides to Poly(pentafluorophenyl acrylate) Grafted Surfaces via Hydrazide Conjugation.

Authors:  Li Chen; Deborah Leman; Caitlin R Williams; Karson Brooks; Duncan C Krause; Jason Locklin
Journal:  Langmuir       Date:  2017-05-18       Impact factor: 3.882

Review 6.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

7.  Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011.

Authors:  Fei Zhao; Gang Liu; Bin Cao; Jiang Wu; Yixin Gu; Lihua He; Fanliang Meng; Liang Zhu; Yudong Yin; Min Lv; Jianzhong Zhang
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

8.  Mycoplasma pneumoniae in children with acute and refractory asthma.

Authors:  Pamela R Wood; Vanessa L Hill; Margaret L Burks; Jay I Peters; Harjinder Singh; Thirumalai R Kannan; Shruthi Vale; Marianna P Cagle; Molly F R Principe; Joel B Baseman; Edward G Brooks
Journal:  Ann Allergy Asthma Immunol       Date:  2013-02-23       Impact factor: 6.347

9.  Distinct Mycoplasma pneumoniae Interactions with Sulfated and Sialylated Receptors.

Authors:  Caitlin R Williams; Li Chen; Edward S Sheppard; Pradeep Chopra; Jason Locklin; Geert-Jan Boons; Duncan C Krause
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

10.  Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China.

Authors:  Guanhua Xue; Qinning Wang; Chao Yan; Neisha Jeoffreys; Liqiong Wang; Shaoli Li; Gwendolyn L Gilbert; Hongmei Sun
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.